OmanDocSign in

Curriculum · Hematology

Choosing the right blood component

What it is

Whole blood is separated into components, and each component has its own volume, storage limit, storage temperature and pre-transfusion preparation time. Red blood cells come as about 300 mL, held at 1-6 °C, with a storage limit of 42 days and 10-45 minutes of preparation. Buffy coat derived platelets, made from 4 units, are about 350 mL at 20-24 °C with 5 minutes of preparation and a storage limit of 5 days, and apheresis platelets are about 330 mL, also 20-24 °C and 5 minutes, and carry the same 5 day limit. Frozen plasma is about 290 mL and apheresis plasma about 500 mL, both at -18 °C or colder with 30 minutes of preparation, and both keep for 1 year. Cryoprecipitate is about 10 mL, also -18 °C or colder and 30 minutes, and it keeps for 1 year as well. These preparation times are in addition to the 45 minutes required for pre-transfusion specimen testing.

How it is treated

Platelet transfusion is indicated by the count together with what is to be done:

A component can also be modified, and each modification meets a particular risk:

The list is read by taking the count together with what is about to be done. Line insertion sits in the minor procedures row, so the number to reach before a line is put in is 20, not the 50 of major procedures where significant blood loss is expected, and not the 10 of a non-immune thrombocytopenia with nothing to be done.

What can go wrong

A reaction during a transfusion is met in a set order: stop the transfusion and maintain iv access, take the patient's vital signs, check the name of the patient against the name on the blood product, notify the physician, and notify the hospital transfusion service, the blood bank, even if the transfusion was restarted or completed. The next question is whether there is a clerical error or serious symptoms, and the serious ones are these: temperature above 39 °C, hypotension or shock, rigors, anxiety, dyspnea, back or chest pain, hemoglobinuria or oliguria, bleeding from iv sites, and nausea or vomiting.